144 related articles for article (PubMed ID: 32935235)
1. Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration.
Ramirez G; Pham AC; Clulow AJ; Salim M; Hawley A; Boyd BJ
Drug Deliv Transl Res; 2021 Jun; 11(3):1236-1244. PubMed ID: 32935235
[TBL] [Abstract][Full Text] [Related]
2. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administration.
Nguyen TH; Hanley T; Porter CJ; Boyd BJ
Drug Deliv Transl Res; 2011 Dec; 1(6):429-38. PubMed ID: 25786363
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
Nguyen TH; Hanley T; Porter CJ; Boyd BJ
J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
[TBL] [Abstract][Full Text] [Related]
6. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
[TBL] [Abstract][Full Text] [Related]
7. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
[TBL] [Abstract][Full Text] [Related]
8. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
[TBL] [Abstract][Full Text] [Related]
9. Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion.
Binte Abu Bakar SY; Salim M; Clulow AJ; Hawley A; Boyd BJ
Int J Pharm; 2019 Jan; 554():179-189. PubMed ID: 30391337
[TBL] [Abstract][Full Text] [Related]
10. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
11. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
12. Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.
Paulus F; Bauer-Brandl A; Stappaerts J; Holm R
Eur J Pharm Sci; 2024 Jan; 192():106634. PubMed ID: 37951315
[TBL] [Abstract][Full Text] [Related]
13. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
Avachat AM; Parpani SS
Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
[TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution and excretion of the anti-tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosis.
Shibata M; Shimokawa Y; Sasahara K; Yoda N; Sasabe H; Suzuki M; Umehara K
Biopharm Drug Dispos; 2017 May; 38(4):301-312. PubMed ID: 28092695
[TBL] [Abstract][Full Text] [Related]
15. Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
Larsen AT; Holm R; Müllertz A
Eur J Pharm Biopharm; 2017 Aug; 117():308-314. PubMed ID: 28465239
[TBL] [Abstract][Full Text] [Related]
16. The influence of lipid digestion on the fate of orally administered drug delivery vehicles.
Boyd BJ; Clulow AJ
Biochem Soc Trans; 2021 Aug; 49(4):1749-1761. PubMed ID: 34431506
[TBL] [Abstract][Full Text] [Related]
17. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
Feeney OM; Williams HD; Pouton CW; Porter CJ
J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
[TBL] [Abstract][Full Text] [Related]
18. Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats.
Lee KW; Porter CJ; Boyd BJ
J Pharm Sci; 2013 Nov; 102(11):3957-65. PubMed ID: 23983139
[TBL] [Abstract][Full Text] [Related]
19. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
Tanaka Y; Doi H; Katano T; Kasaoka S
Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
[TBL] [Abstract][Full Text] [Related]
20. Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability.
Tanaka Y; Nguyen TH; Suys EJA; Porter CJH
Mol Pharm; 2021 Apr; 18(4):1768-1778. PubMed ID: 33729806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]